Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.5 USD | +1.41% | +7.07% | +33.99% |
May. 02 | Needham Adjusts Price Target on Glaukos to $113 From $108, Maintains Buy Rating | MT |
May. 02 | JPMorgan Adjusts Price Target on Glaukos to $110 From $108, Maintains Overweight Rating | MT |
Chart calendar Glaukos Corporation
Upcoming events on Glaukos Corporation
Past events on Glaukos Corporation
2024-05-01 04:30 pm | Q1 2024 Earnings Call |
2024-05-01 04:05 pm | Q1 2024 Earnings Release |
2024-02-21 04:30 pm | Q4 2023 Earnings Call |
2024-02-21 04:05 pm | Q4 2023 Earnings Release |
2024-01-09 08:15 pm | JPMorgan Healthcare Conference |
2023-12-14 08:30 am | IDose®TR FDA Approval Call |
2023-11-14 10:55 am | Stifel Healthcare Conference |
2023-11-04 01:00 pm | American Academy Of Ophthalmology Meeting |
2023-11-03 04:53 pm | American Academy Of Ophthalmology Meeting |
2023-11-01 04:30 pm | Q3 2023 Earnings Call |
2023-11-01 04:05 pm | Q3 2023 Earnings Release |
2023-09-06 12:45 pm | Wells Fargo Healthcare Conference |
2023-08-02 04:30 pm | Q2 2023 Earnings Call |
2023-08-02 04:05 pm | Q2 2023 Earnings Release |
2023-06-07 11:40 am | William Blair Growth Stock Conference |
2023-06-01 12:00 pm | Annual General Meeting |
2023-05-07 06:47 pm | The American Society of Cataract & Refractive Surgery Meeting - Kenneth A. Beckman, MD |
2023-05-07 05:11 pm | The American Society of Cataract & Refractive Surgery Meeting - Philip Dockery, MD |
2023-05-07 04:51 pm | The American Society of Cataract & Refractive Surgery Meeting - Miltos Balidis, Ph.D., MD |
2023-05-07 04:45 pm | The American Society of Cataract & Refractive Surgery Meeting - Julia Yu, BSc |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 237 241 -1.56% | 225 220 2.24% | 294 288 2.03% | 283 280 1.15% | 315 311 1.2% | 362 |
EBITDA Million USD | Released Forecast Spread | -44,0 -18,1 -143.47% | -94,2 -57,7 -63.28% | 7,83 -7,95 198.43% | -55,1 -51,6 -6.85% | -70,1 -71,2 1.48% | -81,0 |
EBIT Million USD | Released Forecast Spread | -50,3 -26,2 -92.01% | -48,2 -73,1 34.04% | -21,8 -26,5 17.46% | -86,7 -82,4 -5.27% | -104 -95,8 -8.38% | -105 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -50,0 -29,2 -71.65% | -132 -122 -8.68% | 0,00 0,00 - | 0,00 0,00 - | -134 -106 -26.23% | -115 |
Net income Million USD | Released Forecast Spread | 15,4 -28,3 154.58% | -120 -120 -0.31% | -49,6 -44,2 -12.16% | -99,2 -90,2 -9.95% | -135 -122 -10.36% | -128 |
EPS USD | Released Forecast Spread | 0,37 -0,72 151.19% | -2,70 -2,68 -0.81% | -1,07 -1,07 0.31% | -2,09 -1,93 -8.2% | -2,78 -2,59 -7.45% | -2,54 |
Announcement Date | 27/02/20 | 25/02/21 | 22/02/22 | 22/02/23 | 21/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 73,2 67,3 8.88% | 67,7 60,9 11.22% | 72,7 68,0 6.91% | 71,3 68,0 4.87% | 71,2 68,1 4.64% | 73,9 67,7 9.1% | 80,4 74,7 7.68% | 78,0 75,3 3.7% | 82,4 78,5 4.88% | 85,6 79,7 7.48% | 88,6 | 89,7 | 99,0 | 103 |
EBITDA Million USD | Released Forecast Spread | -2,81 -11,6 75.75% | -6,03 -17,2 64.95% | -21,1 -14,0 -50.72% | -7,39 -13,5 45.03% | -19,2 -19,1 -0.72% | -18,5 -18,9 2.07% | -13,0 -17,4 25.41% | -13,3 -18,2 26.77% | -23,9 -20,0 -19.66% | -21,7 | -18,6 | -19,7 | -19,3 | -17,4 |
EBIT Million USD | Released Forecast Spread | -10,3 -15,1 31.86% | -13,6 -21,3 35.93% | -30,4 -17,9 -69.89% | -15,3 -20,7 26.2% | -27,4 -22,1 -24.14% | -26,8 -24,5 -9.23% | -22,8 -24,2 5.64% | -21,8 -23,9 8.71% | -32,4 -24,8 -30.4% | -32,8 -27,4 -19.78% | -24,5 | -24,1 | -24,0 | -20,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,2 -16,6 -34.19% | 5,70 -23,7 124.04% | -45,6 -21,8 -109.8% | -27,3 -24,7 -10.52% | -31,2 -25,9 -20.52% | -34,2 -26,3 -30.29% | -32,4 -26,0 -24.53% | -30,4 -26,4 -15.18% | -36,7 -26,2 -40.37% | -40,5 -29,8 -35.85% | -27,6 | -26,4 | -27,1 | -23,4 |
Net income Million USD | Released Forecast Spread | -21,9 -18,2 -20.49% | 5,38 -24,2 122.18% | -45,5 -23,0 -97.63% | -27,6 -25,6 -7.69% | -31,5 -26,6 -18.41% | -34,6 -28,9 -19.61% | -32,8 -28,9 -13.6% | -30,4 -28,2 -7.96% | -36,8 -28,8 -27.69% | -40,8 -31,3 -30.53% | -29,4 | -28,8 | -29,0 | -24,3 |
EPS USD | Released Forecast Spread | -0,47 -0,44 -8.05% | 0,11 -0,44 125.11% | -0,96 -0,52 -84.62% | -0,58 -0,54 -7.98% | -0,66 -0,55 -19.46% | -0,72 -0,60 -19.71% | -0,68 -0,60 -12.53% | -0,63 -0,60 -4.25% | -0,75 -0,61 -22.66% | -0,82 -0,65 -26.64% | -0,59 | -0,59 | -0,58 | -0,49 |
Announcement Date | 22/02/22 | 04/05/22 | 03/08/22 | 02/11/22 | 22/02/23 | 03/05/23 | 02/08/23 | 01/11/23 | 21/02/24 | 01/05/24 | - | - | - | - |
Past sector events for Glaukos Corporation
2024-05-02 06:00 am | ENOVIS CORPORATION: Q1 2024 Earnings Release |
2024-05-01 04:05 pm | GLAUKOS CORPORATION: Q1 2024 Earnings Release |
2024-05-01 02:00 am | SMITH & NEPHEW PLC: Q1 2024 Sales and Revenue Release - Trading Update |
2024-04-30 | JAPAN LIFELINE CO., LTD.: Q4 2023 Earnings Release |
2024-04-30 04:05 pm | STRYKER CORPORATION: Q1 2024 Earnings Release |
2024-04-30 04:01 pm | AXONICS, INC.: Q1 2024 Earnings Release |
2024-04-29 | DOUBLE MEDICAL TECHNOLOGY INC.: Q1 2024 Earnings Release |
2024-04-28 | BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO., LTD.: Q1 2024 Earnings Release |
2024-04-27 | YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD.: Q1 2024 Earnings Release |
2024-04-26 | SINO MEDICAL SCIENCES TECHNOLOGY INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GKOS Stock
- Calendar Glaukos Corporation